WS Management’s Intellia Therapeutics NTLA Stock Holding History

WS Management’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-26,646	Closed	-$812K	–	66
2023 Q4	$812K	Hold	26,646	–	–	0.05%	63
2023 Q3	$843K	Hold	26,646	–	–	0.07%	64
2023 Q2	$1.09M	Hold	26,646	–	–	0.09%	56
2023 Q1	$993K	Hold	26,646	–	–	0.11%	52
2022 Q4	$930K	Hold	26,646	–	–	0.08%	59
2022 Q3	$1.49M	Hold	26,646	–	–	0.14%	58
2022 Q2	$1.38M	Hold	26,646	–	–	0.11%	62
2022 Q1	$1.94M	Hold	26,646	–	–	0.09%	59
2021 Q4	$3.15M	Hold	26,646	–	–	0.25%	47
2021 Q3	$3.58M	Hold	26,646	–	–	0.38%	46
2021 Q2	$4.31M	Sell	26,646 -13,323	-33%	-$1.04M	0.43%	43
2021 Q1	$3.21M	Sell	39,969 -2,049	-5%	-$138K	0.33%	41
2020 Q4	$2.29M	Hold	42,018	–	–	0.24%	44
2020 Q3	$835K	Hold	42,018	–	–	0.09%	57
2020 Q2	$883K	Sell	42,018 -7,212	-15%	-$123K	0.11%	50
2020 Q1	$602K	Sell	49,230 -2,470	-5%	-$33.3K	0.07%	60
2019 Q4	$758K	Hold	51,700	–	–	0.06%	53
2019 Q3	$690K	Sell	51,700 -5,692	-10%	-$90.8K	0.05%	60
2019 Q2	$940K	Sell	57,392 -6,776	-11%	-$107K	0.06%	63
2019 Q1	$1.1M	Sell	64,168 -8,630	-12%	-$129K	0.07%	62
2018 Q4	$994K	Sell	72,798 -47,202	-39%	-$877K	0.05%	77
2018 Q3	$3.43M	Hold	120,000	–	–	0.11%	73
2018 Q2	$3.28M	Buy	+120,000	New	+$2.91M	0.09%	72

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WS Management's NTLA Position: Q1 2024 in Review

WS Management sold out of Intellia Therapeutics (NTLA) in Q1 2024, closing a stake of 26,646 shares — an estimated $812K sold.

WS Management first reported a position in NTLA in Q2 2018 and held it in 23 quarters. The position peaked at $4.31M in Q2 2021. 284 funds tracked by Wall St. Rank hold NTLA as of Q1 2024.

WS Management reported no remaining Intellia Therapeutics position as of Q1 2024 after selling out during the quarter.
WS Management sold 26,646 Intellia Therapeutics shares in Q1 2024, an estimated $812K.
WS Management first reported a position in Intellia Therapeutics in Q2 2018 and held it in 23 quarters.
WS Management's Intellia Therapeutics position peaked at $4.31M in Q2 2021.
284 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2024.

Based on WS Management's 13F filing for Q1 2024, filed 14 May 2024.